世界の神経疾患診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4569
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、神経疾患診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イメージング技術、体外診断技術）、用途別市場規模（病院・クリニック、診断センター、外来診療センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・神経疾患診断の市場動向
・企業の競争状況、市場シェア
・神経疾患診断の種類別市場規模と予測2016-2027（イメージング技術、体外診断技術）
・神経疾患診断の用途別市場規模と予測2016-2027（病院・クリニック、診断センター、外来診療センター）
・神経疾患診断の北米市場規模2016-2027（アメリカ、カナダ）
・神経疾患診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・神経疾患診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・神経疾患診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・神経疾患診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Siemens、Philips、GE、Esaote、Masimo、Croton Healthcare、Neusoft）
・結論

Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.

Market Analysis and Insights: Global Neurological Disorder Diagnostics Market
The global Neurological Disorder Diagnostics market size is projected to reach US$ 13800 million by 2027, from US$ 10080 million in 2020, at a CAGR of 4.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurological Disorder Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurological Disorder Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurological Disorder Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurological Disorder Diagnostics market.

Global Neurological Disorder Diagnostics Scope and Market Size
Neurological Disorder Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Disorder Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Imaging Techniques
In Vitro Diagnostics Techniques

Segment by Application
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurological Disorder Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Imaging Techniques
1.2.3 In Vitro Diagnostics Techniques
1.3 Market by Application
1.3.1 Global Neurological Disorder Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Care Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neurological Disorder Diagnostics Market Perspective (2016-2027)
2.2 Neurological Disorder Diagnostics Growth Trends by Regions
2.2.1 Neurological Disorder Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurological Disorder Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Neurological Disorder Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Neurological Disorder Diagnostics Industry Dynamic
2.3.1 Neurological Disorder Diagnostics Market Trends
2.3.2 Neurological Disorder Diagnostics Market Drivers
2.3.3 Neurological Disorder Diagnostics Market Challenges
2.3.4 Neurological Disorder Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neurological Disorder Diagnostics Players by Revenue
3.1.1 Global Top Neurological Disorder Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Neurological Disorder Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Neurological Disorder Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurological Disorder Diagnostics Revenue
3.4 Global Neurological Disorder Diagnostics Market Concentration Ratio
3.4.1 Global Neurological Disorder Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurological Disorder Diagnostics Revenue in 2020
3.5 Neurological Disorder Diagnostics Key Players Head office and Area Served
3.6 Key Players Neurological Disorder Diagnostics Product Solution and Service
3.7 Date of Enter into Neurological Disorder Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neurological Disorder Diagnostics Breakdown Data by Type
4.1 Global Neurological Disorder Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Neurological Disorder Diagnostics Forecasted Market Size by Type (2022-2027)

5 Neurological Disorder Diagnostics Breakdown Data by Application
5.1 Global Neurological Disorder Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Neurological Disorder Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neurological Disorder Diagnostics Market Size (2016-2027)
6.2 North America Neurological Disorder Diagnostics Market Size by Type
6.2.1 North America Neurological Disorder Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Neurological Disorder Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Neurological Disorder Diagnostics Market Size by Type (2016-2027)
6.3 North America Neurological Disorder Diagnostics Market Size by Application
6.3.1 North America Neurological Disorder Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Neurological Disorder Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Neurological Disorder Diagnostics Market Size by Application (2016-2027)
6.4 North America Neurological Disorder Diagnostics Market Size by Country
6.4.1 North America Neurological Disorder Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Neurological Disorder Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neurological Disorder Diagnostics Market Size (2016-2027)
7.2 Europe Neurological Disorder Diagnostics Market Size by Type
7.2.1 Europe Neurological Disorder Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Neurological Disorder Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Neurological Disorder Diagnostics Market Size by Type (2016-2027)
7.3 Europe Neurological Disorder Diagnostics Market Size by Application
7.3.1 Europe Neurological Disorder Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Neurological Disorder Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Neurological Disorder Diagnostics Market Size by Application (2016-2027)
7.4 Europe Neurological Disorder Diagnostics Market Size by Country
7.4.1 Europe Neurological Disorder Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Neurological Disorder Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neurological Disorder Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Neurological Disorder Diagnostics Market Size by Type
8.2.1 Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurological Disorder Diagnostics Market Size by Application
8.3.1 Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurological Disorder Diagnostics Market Size by Region
8.4.1 Asia-Pacific Neurological Disorder Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurological Disorder Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neurological Disorder Diagnostics Market Size (2016-2027)
9.2 Latin America Neurological Disorder Diagnostics Market Size by Type
9.2.1 Latin America Neurological Disorder Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Neurological Disorder Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Neurological Disorder Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Neurological Disorder Diagnostics Market Size by Application
9.3.1 Latin America Neurological Disorder Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Neurological Disorder Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Neurological Disorder Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Neurological Disorder Diagnostics Market Size by Country
9.4.1 Latin America Neurological Disorder Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Neurological Disorder Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neurological Disorder Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type
10.2.1 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application
10.3.1 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurological Disorder Diagnostics Market Size by Country
10.4.1 Middle East & Africa Neurological Disorder Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Neurological Disorder Diagnostics Introduction
11.1.4 Siemens Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.1.5 Siemens Recent Development
11.2 Philips
11.2.1 Philips Company Details
11.2.2 Philips Business Overview
11.2.3 Philips Neurological Disorder Diagnostics Introduction
11.2.4 Philips Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.2.5 Philips Recent Development
11.3 GE
11.3.1 GE Company Details
11.3.2 GE Business Overview
11.3.3 GE Neurological Disorder Diagnostics Introduction
11.3.4 GE Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.3.5 GE Recent Development
11.4 Esaote
11.4.1 Esaote Company Details
11.4.2 Esaote Business Overview
11.4.3 Esaote Neurological Disorder Diagnostics Introduction
11.4.4 Esaote Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.4.5 Esaote Recent Development
11.5 Masimo
11.5.1 Masimo Company Details
11.5.2 Masimo Business Overview
11.5.3 Masimo Neurological Disorder Diagnostics Introduction
11.5.4 Masimo Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.5.5 Masimo Recent Development
11.6 Croton Healthcare
11.6.1 Croton Healthcare Company Details
11.6.2 Croton Healthcare Business Overview
11.6.3 Croton Healthcare Neurological Disorder Diagnostics Introduction
11.6.4 Croton Healthcare Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.6.5 Croton Healthcare Recent Development
11.7 Neusoft
11.7.1 Neusoft Company Details
11.7.2 Neusoft Business Overview
11.7.3 Neusoft Neurological Disorder Diagnostics Introduction
11.7.4 Neusoft Revenue in Neurological Disorder Diagnostics Business (2016-2021)
11.7.5 Neusoft Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neurological Disorder Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Imaging Techniques
Table 3. Key Players of In Vitro Diagnostics Techniques
Table 4. Global Neurological Disorder Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Neurological Disorder Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neurological Disorder Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Neurological Disorder Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Neurological Disorder Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Neurological Disorder Diagnostics Market Share by Regions (2022-2027)
Table 10. Neurological Disorder Diagnostics Market Trends
Table 11. Neurological Disorder Diagnostics Market Drivers
Table 12. Neurological Disorder Diagnostics Market Challenges
Table 13. Neurological Disorder Diagnostics Market Restraints
Table 14. Global Neurological Disorder Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Neurological Disorder Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Neurological Disorder Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Diagnostics as of 2020)
Table 17. Ranking of Global Top Neurological Disorder Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Neurological Disorder Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neurological Disorder Diagnostics Product Solution and Service
Table 21. Date of Enter into Neurological Disorder Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Neurological Disorder Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Neurological Disorder Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Neurological Disorder Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Neurological Disorder Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Neurological Disorder Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Neurological Disorder Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Neurological Disorder Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Neurological Disorder Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Neurological Disorder Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Neurological Disorder Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Neurological Disorder Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Neurological Disorder Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Neurological Disorder Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Neurological Disorder Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Neurological Disorder Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Neurological Disorder Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Neurological Disorder Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neurological Disorder Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Neurological Disorder Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Neurological Disorder Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Neurological Disorder Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Neurological Disorder Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Neurological Disorder Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Neurological Disorder Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neurological Disorder Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Neurological Disorder Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Siemens Company Details
Table 62. Siemens Business Overview
Table 63. Siemens Neurological Disorder Diagnostics Product
Table 64. Siemens Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Siemens Recent Development
Table 66. Philips Company Details
Table 67. Philips Business Overview
Table 68. Philips Neurological Disorder Diagnostics Product
Table 69. Philips Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Philips Recent Development
Table 71. GE Company Details
Table 72. GE Business Overview
Table 73. GE Neurological Disorder Diagnostics Product
Table 74. GE Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 75. GE Recent Development
Table 76. Esaote Company Details
Table 77. Esaote Business Overview
Table 78. Esaote Neurological Disorder Diagnostics Product
Table 79. Esaote Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Esaote Recent Development
Table 81. Masimo Company Details
Table 82. Masimo Business Overview
Table 83. Masimo Neurological Disorder Diagnostics Product
Table 84. Masimo Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Masimo Recent Development
Table 86. Croton Healthcare Company Details
Table 87. Croton Healthcare Business Overview
Table 88. Croton Healthcare Neurological Disorder Diagnostics Product
Table 89. Croton Healthcare Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Croton Healthcare Recent Development
Table 91. Neusoft Company Details
Table 92. Neusoft Business Overview
Table 93. Neusoft Neurological Disorder Diagnostics Product
Table 94. Neusoft Revenue in Neurological Disorder Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Neusoft Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurological Disorder Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Imaging Techniques Features
Figure 3. In Vitro Diagnostics Techniques Features
Figure 4. Global Neurological Disorder Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Ambulatory Care Centers Case Studies
Figure 8. Neurological Disorder Diagnostics Report Years Considered
Figure 9. Global Neurological Disorder Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Neurological Disorder Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neurological Disorder Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global Neurological Disorder Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global Neurological Disorder Diagnostics Market Share by Players in 2020
Figure 14. Global Top Neurological Disorder Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Neurological Disorder Diagnostics Revenue in 2020
Figure 16. Global Neurological Disorder Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global Neurological Disorder Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Neurological Disorder Diagnostics Market Share by Type (2016-2027)
Figure 20. North America Neurological Disorder Diagnostics Market Share by Application (2016-2027)
Figure 21. North America Neurological Disorder Diagnostics Market Share by Country (2016-2027)
Figure 22. United States Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neurological Disorder Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe Neurological Disorder Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe Neurological Disorder Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neurological Disorder Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Neurological Disorder Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Neurological Disorder Diagnostics Market Share by Region (2016-2027)
Figure 38. China Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neurological Disorder Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America Neurological Disorder Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America Neurological Disorder Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neurological Disorder Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Neurological Disorder Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Neurological Disorder Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Neurological Disorder Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Siemens Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 58. Philips Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 59. GE Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 60. Esaote Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 61. Masimo Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 62. Croton Healthcare Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 63. Neusoft Revenue Growth Rate in Neurological Disorder Diagnostics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4124 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

神経疾患診断のグローバル市場：規模・現状・予測2019-2025

Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2019-2025
QYR9NV18208 2019年11月18日 95Pages
※当調査レポートでは、神経疾患診断の世界市場について調査・分析し、神経疾患診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（イメージング技術、体外診断技術）、用途別（病院およびクリニック、診断セン...

神経疾患診断のグローバル市場：規模・現状・予測2019-2025

世界の排卵障害診断市場規模・現状・予測（2021年-2027年）

Global Ovulation Disorder Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-5286 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、排卵障害診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン検査、視床下部検出、卵巣生検、その他）、用途別市場規模（病院、婦人科クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の甲状腺障害市場規模・現状・予測（2021年-2027年）

Global Thyroid Disorder Market Size, Status and Forecast 2021-2027
QFJ1-6041 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、甲状腺障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のHPV関連疾患市場規模・現状・予測（2021年-2027年）

Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4327 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、HPV関連疾患の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（予防、治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の強迫性障害治療薬市場規模・現状・予測（2021年-2027年）

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5903 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、強迫性障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、TCA、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年）

Global Opioid Use Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4617 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、オピオイド使用障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、メタドン、ナルトレキソン）、用途別市場規模（中等度疼痛治療、重度疼痛治療）、主要地域別市場規模（北米、アメリカ、欧州...

世界の物質使用障害治療市場規模・現状・予測（2021年-2027年）

Global Substance Use Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4914 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、物質使用障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、用途別市場規模（病院、クリニック、在宅医療設備）、主要地域別市場規模（北米、アメリ...

神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…
神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…
世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CA…
世界の排卵障害診断市場規模・現状・予測（2021年-2027年） Some significant driving factors for the growth of the ovulation disorder diagnosis market include increasing genetic and hormonal disorders, rising obesity rates, the increasing prevalence of diabetes around the world. Market Analysis and Insights: Global Ovulation Disorder Diagnosis Market The glo…
世界の体外診断（IVD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics(IVD) Market The global In Vitro Diagnostics(IVD) market size is projected to reach US$ 120900 million by 2027, from US$ 76910 million in 2020, at a CAGR of 6.6% during 2021-2027. With industry-standard accuracy in analysis and high data integ…